Skip to main content

Published locations for FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years

User login

  • Reset your password
  • /content/fda-approves-anifrolumab-saphnelo-first-new-lupus-treatment-more-10-years
  • /edermatologynews/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo
  • /familypracticenews/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo
  • /internalmedicinenews/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab
  • /rheumatologynews/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo
  • /jcomjournal/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo-first
  • /rheumatology/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo-first
  • /internalmedicine/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo
  • /dermatology/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo-first
  • /familymedicine/article/243776/lupus-connective-tissue-diseases/fda-approves-anifrolumab-saphnelo